Characterization of contractile function in diabetic hypertensive cardiomyopathy in adult rat ventricular myocytes

L E Wold1, D P Relling, P B Colligan

  • 1Department of Pharmacology, Physiology and Therapeutics, University of North Dakota School of Medicine, Grand Forks, ND 58203, USA.

Insights

Diabetic cardiomyopathy and hypertensive cardiomyopathy worsen heart function. Combining diabetes and hypertension severely impairs cardiac contractility at the single myocyte level, increasing cardiovascular risk.

Area of Science:

  • Cardiovascular physiology
  • Diabetology
  • Hypertension research

Background:

  • Diabetes and hypertension independently cause myocardial dysfunction, increasing cardiovascular morbidity and mortality.
  • The combined effect of diabetes and hypertension on cardiac function is often more severe than either condition alone.

Purpose of the Study:

  • To investigate the impact of combined diabetes and hypertension on cardiac contractile function at the single ventricular myocyte level.
  • To characterize the specific cellular mechanisms underlying diabetic hypertensive cardiomyopathy.

Main Methods:

  • Adult spontaneously hypertensive rats (SHR) and Wistar-Kyoto (WKY) rats were induced into diabetes using streptozotocin (STZ).
  • Ventricular myocyte contractile properties, including peak shortening (PS), time-to-peak shortening (TPS), time-to-90% relengthening (TR90), and maximal shortening/relengthening velocities (+/-dL/dt), were assessed.
  • Responsiveness to extracellular calcium (Ca2+) and stimulus frequency-response curves were evaluated.

Main Results:

  • Diabetic hypertensive rats (SHR-STZ) exhibited enlarged hearts, hyperglycemia, and elevated blood pressure.
  • Myocytes from SHR-STZ showed depressed peak shortening and prolonged contraction/relaxation times compared to controls.
  • Impaired calcium responsiveness was observed in diabetic myocytes (WKY-STZ), while hypertensive myocytes (SHR, SHR-STZ) displayed reduced maximal shortening/relengthening velocities.
  • The SHR-STZ group demonstrated an altered stimulus frequency-peak shortening relationship, indicating significant contractile dysfunction.

Conclusions:

  • The combination of diabetes and hypertension leads to a greater impairment of cardiac contractile function at the single myocyte level than either condition individually.
  • Diabetic hypertensive cardiomyopathy involves complex alterations in myocyte mechanics, calcium handling, and responsiveness to stimulation.
  • These findings underscore the critical need for integrated management strategies for patients with both diabetes and hypertension to mitigate severe cardiac outcomes.